<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: <z:hpo ids='HP_0003074'>Hyperglycemia</z:hpo> is linked to a worse outcome after <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Among the manifestations of brain damage caused by <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> are blood-brain barrier (<z:chebi fb="2" ids="33602">BBB</z:chebi>) disruption and <z:hpo ids='HP_0000969'>edema</z:hpo> formation </plain></SENT>
<SENT sid="2" pm="."><plain><z:mp ids='MP_0003674'>Oxidative stress</z:mp> and matrix metalloproteinase-9 (MMP-9) activation are implicated in <z:chebi fb="2" ids="33602">BBB</z:chebi> dysfunction after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion injury </plain></SENT>
<SENT sid="3" pm="."><plain>Our present study was designed to clarify the relation among <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo>, <z:mp ids='MP_0003674'>oxidative stress</z:mp>, and MMP-9 activation associated with <z:chebi fb="2" ids="33602">BBB</z:chebi> dysfunction after transient focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> (tFCI) </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: We used a model of 60 minutes of middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> on the following animals: normoglycemic <z:mp ids='MP_0002169'>wild-type</z:mp> rats, <z:mp ids='MP_0002169'>wild-type</z:mp> rats with <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> induced by <z:chebi fb="1" ids="9288">streptozotocin</z:chebi>, and human copper/zinc <z:chebi fb="1" ids="18421">superoxide</z:chebi> dismutase (SOD1) transgenic rats with <z:chebi fb="1" ids="9288">streptozotocin</z:chebi>-induced <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>We evaluated <z:hpo ids='HP_0000969'>edema</z:hpo> volume, Evans blue leakage, and <z:mp ids='MP_0003674'>oxidative stress</z:mp>, such as the <z:chebi fb="0" ids="23019">carbonyl groups</z:chebi> and oxidized hydroethidine (HEt), SOD activity, and gelatinolytic activity, including MMP-9 </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: <z:hpo ids='HP_0003074'>Hyperglycemia</z:hpo> significantly increased <z:hpo ids='HP_0000969'>edema</z:hpo> volume and Evans blue leakage </plain></SENT>
<SENT sid="7" pm="."><plain>Moreover, it enhanced the levels of the <z:chebi fb="0" ids="23019">carbonyl groups</z:chebi>, the oxidized HEt signals, and MMP-9 activity after tFCI without alteration in SOD activity </plain></SENT>
<SENT sid="8" pm="."><plain>Gelatinolytic activity and oxidized HEt signals had a clear spatial relation in the hyperglycemic rats </plain></SENT>
<SENT sid="9" pm="."><plain>SOD1 overexpression reduced the <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo>-enhanced Evans blue leakage and MMP-9 activation after tFCI </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: <z:hpo ids='HP_0003074'>Hyperglycemia</z:hpo> increases <z:mp ids='MP_0003674'>oxidative stress</z:mp> and MMP-9 activity, exacerbating <z:chebi fb="2" ids="33602">BBB</z:chebi> dysfunction after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion injury </plain></SENT>
<SENT sid="11" pm="."><plain><z:chebi fb="1" ids="18421">Superoxide</z:chebi> overproduction may be a causal link among <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo>, MMP-9 activation, and <z:chebi fb="2" ids="33602">BBB</z:chebi> dysfunction </plain></SENT>
</text></document>